These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 15336472

  • 1. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
    Tardif JC, Ducharme A, Yu H, Wogen J, Guertin MC.
    Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
    L'Allier PL, Ducharme A, Keller PF, Yu H, Guertin MC, Tardif JC.
    J Am Coll Cardiol; 2004 Jul 07; 44(1):159-64. PubMed ID: 15234426
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
    Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, Meador KJ.
    JAMA Neurol; 2024 Aug 01; 81(8):866-874. PubMed ID: 38884986
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M.
    Hypertension; 2021 Mar 03; 77(3):833-842. PubMed ID: 33423528
    [Abstract] [Full Text] [Related]

  • 5. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
    Hsiao FC, Tung YC, Chou SH, Wu LS, Lin CP, Wang CL, Lin YS, Chang CJ, Chu PH.
    Medicine (Baltimore); 2015 Dec 03; 94(51):e2355. PubMed ID: 26705234
    [Abstract] [Full Text] [Related]

  • 6. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May 03; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 7. Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical Trial.
    Yamal JM, Martinez J, Osani MC, Du XL, Simpson LM, Davis BR.
    JAMA Netw Open; 2023 Dec 01; 6(12):e2344998. PubMed ID: 38048133
    [Abstract] [Full Text] [Related]

  • 8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 9. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ, Palmer AJ, Beevers DG, Coles EC, Ledingham JG, Petrie JC, Webster J.
    J Hum Hypertens; 1997 Apr 11; 11(4):205-11. PubMed ID: 9185024
    [Abstract] [Full Text] [Related]

  • 10. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
    Haroon S, Subramanian A, Cooper J, Anand A, Gokhale K, Byne N, Dhalla S, Acosta-Mena D, Taverner T, Okoth K, Wang J, Chandan JS, Sainsbury C, Zemedikun DT, Thomas GN, Parekh D, Marshall T, Sapey E, Adderley NJ, Nirantharakumar K.
    BMC Infect Dis; 2021 Mar 15; 21(1):262. PubMed ID: 33722197
    [Abstract] [Full Text] [Related]

  • 11. Effect of calcium channel blockers on influenza incidence: a population-based retrospective cohort study using administrative claims data in Japan.
    Imai T, Hashimoto H, Kanda N, Sasabuchi Y, Matsui H, Yasunaga H, Hatakeyama S.
    BMJ Open; 2024 Oct 15; 14(10):e084092. PubMed ID: 39414280
    [Abstract] [Full Text] [Related]

  • 12. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

  • 13. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
    Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI.
    Clin Ther; 1997 Dec 15; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
    [Abstract] [Full Text] [Related]

  • 14. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.
    Orv Hetil; 2019 Mar 15; 160(9):343-348. PubMed ID: 30798621
    [Abstract] [Full Text] [Related]

  • 15. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
    Sapienza S, Sacco P, Floyd K, DiCesare J, Doan QD.
    Clin Ther; 2003 Jun 15; 25(6):1872-87. PubMed ID: 12860503
    [Abstract] [Full Text] [Related]

  • 16. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men.
    Kwok T, Leung J, Barrett-Connor E, Osteoporotic Fractures in Men (MrOS) Research Group.
    Age Ageing; 2017 Jan 10; 46(1):57-64. PubMed ID: 28181652
    [Abstract] [Full Text] [Related]

  • 17. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
    Vouri SM, Jiang X, Manini TM, Solberg LM, Pepine C, Malone DC, Winterstein AG.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918425. PubMed ID: 31880802
    [Abstract] [Full Text] [Related]

  • 18. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
    Burke TA, Sturkenboom MC, Ohman-Strickland PA, Wentworth CE, Rhoads GG.
    Pharmacoepidemiol Drug Saf; 2007 Sep 02; 16(9):979-87. PubMed ID: 17605137
    [Abstract] [Full Text] [Related]

  • 19. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA, Kulinskaya E, Steel N.
    BMJ Open; 2017 Jan 24; 7(1):e013570. PubMed ID: 28119386
    [Abstract] [Full Text] [Related]

  • 20. [One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Medvegy M, Wittmann I.
    Orv Hetil; 2023 Aug 27; 164(34):1337-1341. PubMed ID: 37634155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.